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Clinical and pathological features of duodenal GISTs treated with minimal
surgical resection.
Sex e n (%)
M 5 (62.5%)
F 3 (37.5%)
M/F 1.66
Age - years
Mean; SD 57.3; 14.3
Range 28e76
Location e n (%)
D1 2 (25.0%)
D2 1 (12.5%)
D3 2 (25.0%)
D4 3 (37.5%)
Symptoms e n (%)
Gastrointestinal bleeding/anemia 4 (50.0%)
Abdominal pain 1 (12.5%)
Diarrhea 1 (12.5%)
Incidental diagnosis 2 (25.0%)
Resection e n (%)
Duodenal resection þ end to end anastomosis 2 (25.0%)
Wedge resection 6 (75.0%)
Tumor’s diameter e cm
Mean; SD 3.7; 2.0
Range 1.5e8
Mitosis e n/50HPF
Mean; SD 9.75; 17,3
Range 0e52
Risk Classification e n (%)
Very low risk 1 (12.5%)
Low risk 4 (50.0%)
High risk 3 (37.5%)Dear Editor,
We read with great interest the manuscript by Duffaud
and co-authors focused on the conservative management
of duodenal GISTs1 and we would like to further discuss
this approach.
Duodenal GISTs are rare neoplasms, but the surgical
strategy might be challenging in relation to the proximity
to the surrounding structures as the biliary tree or the
pancreas.
According to this, a pancreaticoduodenotomy might be
required. It seems important to highlight, however, that as
stated by the NCCN guidelines the goal of surgical treat-
ment is a complete resection of the tumor with negative
microscopic margins, avoiding whenever possible tumor’s
rupture.2 Moreover a lymphadenectomy is usually not
required, because nodal metastases are very rare in sporadic
GISTs,2 although are common in a setting of Carney Triad
or in pediatric GISTs.3
From 1999 to-date 92 patients underwent surgical resec-
tion for GIST at our Department and among these, 8 pa-
tients underwent a surgical treatment for duodenal GIST
(8.69% of our case series, previously described4e6),
Table 1.
We reported a mild prevalence of males and a mean age
at presentation of 57.3 years, in keeping with Duffaund’s
findings,1 even though we reported a prevalence of D4 lo-
calizations and a smaller mean tumor’s diameter.
Pre-operative work-out was consistent with a clinical
diagnosis of stromal tumors in all cases (Fig. 1).
Notably none of the patients underwent a pancreatico-
duodenotomy, but all tumors were considerate suitable for
a minimal resection with preservation of the pancreas and
the biliary structures.
All the resections, anastomosis and sutures were care-
fully reviewed intra-operatively and were consideredDOI of original article: http://dx.doi.org/10.1016/j.ejso.2014.04.011
http://dx.doi.org/10.1016/j.ejso.2015.03.232
0748-7983/ 2015 Elsevier Ltd. All rights reserved.tension-free, thus a reconstruction using a jejunal Roux
and Y anastomosis was not required.6
All the resections were proved to be R0 at the pathological
examination, with freemargins. All tumorswere c-kit positive
and fivewere concurrentlyCD34 positive (whereasCD34was
not tested in the remaining 3 patients). DOG1 was investi-
gated in three patients resulting positive in all the cases.
Even though the 50.0% of the patients were classified in the
low-risk group, the 37.5%was considered as high-risk GISTs.
Post-operative course was un-eventful in six patients
(75%): one patient had a post-operative chylous fistulaFollow-up e months
Mean; SD 62.0; 44.9
Range 4e128
Figure 1. Duodenal GIST of the first portion. a. Endoscopy; b. contrast-
enhanced abdominal CT scan; c. Wedge duodenal resection with primary
suture.
806 Correspondence / EJSO 41 (2015) 805e807(Claviens’s C27) - and another patient had a post-operative
bleeding (Clavien’s C3).
Mean follow-up was of 62.0 months. One high-risk pa-
tient underwent adjuvant treatment (Imatinib) and experi-
enced a recurrence after 62 months; the patient died due
to disease-progression 90 months after the surgical
treatment.
As Duffaund and co-authors suggested, relapses might
be related to risk criteria and cellular type, rather than the
surgical approach, in line with the results reported by John-
ston and our experience.1,8
However, Hoeppner, consistently also with our findings,
documented that a high-risk duodenal GIST might not be
in-frequent since 3/9 (33%) of the tumors he reported
were at high risk.9
Even if the long-term results of local resections are com-
parable to the ones obtained by pancreaticoduodenectomies,tumor’s location, diameter and duodenal vascularisation
might represent limitations to a conservative treatment,
thus a multidisciplinary approach is highly recommend in
order to evaluate the optimal strategy and a possible neo-
adjuvant treatment.
In conclusion, we agree with the authors in favouring the
preservation of pancreas whenever possible, but on the ba-
sis of our experience and of the review of the literature, we
also identified some key-features that surgeons should care-
fully evaluate in the management of duodenal GISTs, in or-
der to assess the feasibility of a local resection:
1. Patients should be carefully staged in order to assess a
possible involvement of the surrounding structures e.g.
biliary tree and pancreas.
2. Kamath and Johnston reported a mean diameter of
2.5 cm and 3.5 cm for duodenal GISTs treated with
local resection and a mean diameter 5.0 cm and 7 cm
for GISTs requiring a pancreaticoduodenotomy,8,10
therefore it would be recommended to discuss in a
multidisciplinary team the management of large tumors
>5 cm and/or involving the papilla. Indeed, a local
resection could be a possible option whenever the tu-
mor could be managed with a R0 procedure.
3. Local resections could be performed with a wedge or a
duodenal resection. The defect of the wall might be
closed with a primary suture, with an end-to-end anas-
tomosis or with a jejunal-duodenal anastomosis, in rela-
tion to the position or the tension derived by the
sutures. A duodenal trans-resection could be a possible
choice if the marginal vascularisation is conservable.6
On this basis, a pancreaticoduodenotomy should be
considered for large GISTs tumors involving the papilla,
the biliary tree or the pancreas, since it has been associated
with a longer hospital stay, a higher morbidity rate and with
similar outcome comparing with local resections.8
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